Niagen Bioscience, Inc. (NAGE) vs Sionna Therapeutics, Inc. (SION)
Niagen Bioscience, Inc. and Sionna Therapeutics, Inc. are both Biotechnology companies. Niagen Bioscience, Inc. and Sionna Therapeutics, Inc. are of similar size ($241.9M and $238.2M). Sionna Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. Niagen Bioscience, Inc. has the higher net margin (12.4% vs 0.00%) and the higher return on invested capital (42.0% vs −125.0%). Across the 12 metrics below, Niagen Bioscience, Inc. leads on 9 and Sionna Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | NAGE | SION | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.24% | — | 65.16% |
| Operating margin | 8.21% | 0.00% | 0.00% |
| Net margin | 12.39% | 0.00% | 0.00% |
| Free cash flow margin | 8.89% | 0.00% | 0.00% |
| Return on equity | 21.80% | (32.34%) | (57.72%) |
| Return on assets | 16.14% | (30.66%) | (49.22%) |
| Return on invested capital | 41.95% | (125.00%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack